Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$70.62M
Expense Ratio	1.32%
PE Ratio	n/a
Shares Out	2.75M
Dividend (ttm)	$0.70
Dividend Yield	2.84%
Ex-Dividend Date	Dec 30, 2025
Payout Frequency	n/a
Payout Ratio	n/a

Volume	607,569
Open	24.59
Previous Close	24.25
Day's Range	24.08 - 25.43
52-Week Low	9.60
52-Week High	28.44
Beta	n/a
Holdings	12
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Top 10 Holdings

259.79% of assets

Name	Symbol	Weight
ELI LILLY & CO SWAP MS	n/a	36.39%
ELI LILLY & CO SWAP MAREX	n/a	31.50%
ELI LILLY & CO SWAP CS	n/a	30.33%
LLY SWAP NOMURA	n/a	28.41%
ELI LILLY AND COMPANY-SWAP-NBCB-L	n/a	28.13%
ELI LILLY & CO SWAP Cantor - L	n/a	27.42%
US DOLLARS	n/a	24.21%
ELI LILLY & CO SWAP BMO	n/a	20.46%
OTHER ASSETS AND LIABILITIES	n/a	17.01%
First American Government Obligations Fund	FGXXX	15.93%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.70417	Dec 31, 2025

Performance

LLYX had a total return of 60.46% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.00%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Jun 26, 2026

Data Sources Report a data error